Łukasz Bołkuń

822 total citations
52 papers, 510 citations indexed

About

Łukasz Bołkuń is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Łukasz Bołkuń has authored 52 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 21 papers in Genetics and 16 papers in Molecular Biology. Recurrent topics in Łukasz Bołkuń's work include Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (15 papers) and Multiple Myeloma Research and Treatments (11 papers). Łukasz Bołkuń is often cited by papers focused on Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (15 papers) and Multiple Myeloma Research and Treatments (11 papers). Łukasz Bołkuń collaborates with scholars based in Poland, United States and Germany. Łukasz Bołkuń's co-authors include Janusz Kłoczko, Dorota Lemancewicz, J Dzięcioł, Marcin Moniuszko, Ewa Jabłońska, Jarosław Piszcz, Andrzej Eljaszewicz, Mariusz Z. Ratajczak, Agnieszka Kulczyńska‐Przybik and Małgorzata Rusak and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Cancer.

In The Last Decade

Łukasz Bołkuń

46 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Łukasz Bołkuń Poland 14 187 181 160 158 111 52 510
Yoko Okitsu Japan 15 320 1.7× 186 1.0× 198 1.2× 95 0.6× 110 1.0× 49 647
Normann Steiner Austria 14 219 1.2× 180 1.0× 191 1.2× 54 0.3× 98 0.9× 55 471
Ning‐ning Shan China 15 135 0.7× 309 1.7× 86 0.5× 203 1.3× 100 0.9× 49 603
Josephine L. Klitgaard United States 7 178 1.0× 108 0.6× 133 0.8× 111 0.7× 171 1.5× 11 426
Yaqiong Tang China 12 130 0.7× 151 0.8× 75 0.5× 108 0.7× 108 1.0× 34 422
Idanna Innocenti Italy 14 173 0.9× 152 0.8× 131 0.8× 181 1.1× 336 3.0× 75 638
Koshi Akahane Japan 14 301 1.6× 181 1.0× 217 1.4× 99 0.6× 94 0.8× 63 658
Gaetano Vitelli Italy 14 308 1.6× 130 0.7× 186 1.2× 154 1.0× 298 2.7× 28 673
Julie A. Di Paolo United States 9 100 0.5× 116 0.6× 134 0.8× 168 1.1× 131 1.2× 17 521
Danielle Shafer United States 12 169 0.9× 118 0.7× 151 0.9× 48 0.3× 49 0.4× 30 398

Countries citing papers authored by Łukasz Bołkuń

Since Specialization
Citations

This map shows the geographic impact of Łukasz Bołkuń's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Łukasz Bołkuń with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Łukasz Bołkuń more than expected).

Fields of papers citing papers by Łukasz Bołkuń

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Łukasz Bołkuń. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Łukasz Bołkuń. The network helps show where Łukasz Bołkuń may publish in the future.

Co-authorship network of co-authors of Łukasz Bołkuń

This figure shows the co-authorship network connecting the top 25 collaborators of Łukasz Bołkuń. A scholar is included among the top collaborators of Łukasz Bołkuń based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Łukasz Bołkuń. Łukasz Bołkuń is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Drozd‐Sokołowska, Joanna, et al.. (2024). T-cell acute lymphoblastic leukemia with involvement of extramedullary sites, including the pericardium. Kardiologia Polska. 83(1). 83–84.
3.
4.
Bołkuń, Łukasz, Joanna Drozd‐Sokołowska, Ewa Zarzycka, et al.. (2024). A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience. Frontiers in Oncology. 14. 1395992–1395992.
5.
Puła, Bartosz, et al.. (2024). Checkpoint inhibitors as potential therapeutics in acute myeloid leukemia. Acta Haematologica Polonica. 55(6). 343–353. 2 indexed citations
6.
Bołkuń, Łukasz, Jarosław Piszcz, Agnieszka Wierzbowska, et al.. (2023). The Association between Immune Checkpoint Proteins and Therapy Outcomes in Acute Myeloid Leukaemia Patients. Cancers. 15(18). 4487–4487.
7.
Bołkuń, Łukasz, Joanna Godzień, Karolina Pietrowska, et al.. (2023). Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy. Scientific Reports. 13(1). 21809–21809. 11 indexed citations
8.
Drozd‐Sokołowska, Joanna, Ewa Paszkiewicz‐Kozik, Marta Morawska, et al.. (2023). Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group. Annals of Hematology. 102(8). 2119–2126. 4 indexed citations
9.
Bołkuń, Łukasz, et al.. (2022). A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. Journal of Clinical Medicine. 11(16). 4663–4663.
10.
Żebrowska, Agnieszka, et al.. (2021). No increase in anti‐A isohemagglutinin titer after SARS‐CoV‐2 infection: A retrospective cohort analysis of group O apheresis platelet donors. Journal of Clinical Apheresis. 36(6). 882–885. 2 indexed citations
11.
Buske, Christian, Shalal Sadullah, Efstathios Kastritis, et al.. (2018). Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review. The Lancet Haematology. 5(7). e299–e309. 28 indexed citations
12.
13.
Bołkuń, Łukasz, Kamil Grubczak, Gabriela Schneider, et al.. (2016). Involvement of BAFF and APRIL in Resistance to Apoptosis of Acute Myeloid Leukemia. Journal of Cancer. 7(14). 1979–1983. 14 indexed citations
14.
Rusak, Małgorzata, et al.. (2016). Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients. Blood Cells Molecules and Diseases. 59. 92–96. 7 indexed citations
15.
Rusak, Małgorzata, Andrzej Eljaszewicz, Łukasz Bołkuń, et al.. (2015). Prognostic significance of PD‑1 expression on peripheral blood CD4+ T cells in patients with newly diagnosed chronic lymphocytic leukemia. Polskie Archiwum Medycyny Wewnętrznej. 125(7-8). 553–559. 30 indexed citations
16.
Bołkuń, Łukasz, Dorota Lemancewicz, Ewa Jabłońska, et al.. (2014). Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia. Leukemia Research. 39(3). 290–295. 2 indexed citations
17.
Bołkuń, Łukasz, Dorota Lemancewicz, Ewa Jabłońska, et al.. (2014). The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Annals of Hematology. 94(1). 35–43. 11 indexed citations
18.
Bołkuń, Łukasz, et al.. (2014). Assessment of proteasome concentration and chymotrypsin-like activity in plasma of patients with newly diagnosed multiple myeloma. Leukemia Research. 38(8). 925–930. 20 indexed citations
19.
Bołkuń, Łukasz, et al.. (2013). The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment. Advances in Medical Sciences. 58(1). 118–125. 9 indexed citations
20.
Lemancewicz, Dorota, et al.. (2012). The levels of sMUC-1 in patients with multiple myeloma. Folia Histochemica et Cytobiologica. 49(4). 654–658. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Okitsu Breakdown of academic impact, for papers by Normann Steiner Breakdown of academic impact, for papers by Ning‐ning Shan Breakdown of academic impact, for papers by Josephine L. Klitgaard Breakdown of academic impact, for papers by Yaqiong Tang Breakdown of academic impact, for papers by Idanna Innocenti Breakdown of academic impact, for papers by Koshi Akahane Breakdown of academic impact, for papers by Gaetano Vitelli Breakdown of academic impact, for papers by Julie A. Di Paolo Breakdown of academic impact, for papers by Danielle Shafer
Rankless by CCL
2026